🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Inje University Pusan Paik Hospital
Start Date
2011-01
Trial ID
NCT01340131
Treatments Being Tested
A non-randomized, two-arm, single-sequence, crossover, open label, multiple...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02933658
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of HB-1, ...
Status
Suspended
Location
Paratus Clinical Research Canberra
Start Date
2024-10-29
Trial ID
NCT06483789
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Inje Unuversity Pusan Paik Hospital
Start Date
2010-11
Trial ID
NCT01246193
Treatments Being Tested
This is a 2 by 2 cross-over study to evaluate pharmacokinetics of telmisart...
Status
Completed
Location
Severance Hospital
Start Date
2013-07
Trial ID
NCT01975961
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01352689
Treatments Being Tested
The investigators propose a clinical study of irbersartan for the early tre...
Status
Unknown
Location
Università di Salerno
Start Date
2014-01
Trial ID
NCT01992796
Treatments Being Tested
Group 1: To investigate safety, tolerability and pharmacokinetics of Telmi...
Status
Completed
Location
Multiple Locations
Start Date
2003-12-01
Trial ID
NCT02262780
Treatments Being Tested
This study evaluates the safety and pharmacokinetic drug-drug interactions ...
Status
Unknown
Location
Dong-A National University Hospital
Start Date
2018-02-01
Trial ID
NCT03438955
Treatments Being Tested